Dr. Reddy's Laboratories Limited
RDY
$13.03
-$0.23-1.74%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 3.78B | 3.97B | 3.98B | 3.93B | 3.85B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 3.78B | 3.97B | 3.98B | 3.93B | 3.85B |
| Cost of Revenue | 1.78B | 1.78B | 1.73B | 1.66B | 1.60B |
| Gross Profit | 2.00B | 2.19B | 2.25B | 2.27B | 2.25B |
| SG&A Expenses | 1.20B | 1.18B | 1.17B | 1.14B | 1.11B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -31.54M | -40.36M | -38.83M | -36.97M | -33.30M |
| Total Operating Expenses | 3.22B | 3.22B | 3.17B | 3.09B | 3.00B |
| Operating Income | 563.83M | 752.00M | 812.62M | 842.01M | 852.07M |
| Income Before Tax | 627.01M | 837.65M | 886.33M | 904.97M | 908.01M |
| Income Tax Expenses | 142.00M | 192.58M | 208.61M | 230.53M | 231.43M |
| Earnings from Continuing Operations | 485.02 | 645.07 | 677.73 | 674.44 | 676.59 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 4.37M | 5.18M | 4.04M | -7.45M | -8.40M |
| Net Income | 489.39M | 650.25M | 681.76M | 666.99M | 668.18M |
| EBIT | 563.83M | 752.00M | 812.62M | 842.01M | 852.07M |
| EBITDA | 776.85M | 962.24M | 1.02B | 1.04B | 1.04B |
| EPS Basic | 0.59 | 0.78 | 0.82 | 0.80 | 0.80 |
| Normalized Basic EPS | 0.46 | 0.62 | 0.66 | 0.67 | 0.66 |
| EPS Diluted | 0.59 | 0.78 | 0.82 | 0.80 | 0.80 |
| Normalized Diluted EPS | 0.46 | 0.62 | 0.66 | 0.67 | 0.66 |
| Average Basic Shares Outstanding | 3.33B | 3.33B | 3.33B | 3.33B | 3.33B |
| Average Diluted Shares Outstanding | 3.33B | 3.33B | 3.33B | 3.34B | 3.34B |
| Dividend Per Share | 0.08 | 0.09 | 0.09 | 0.09 | 0.09 |
| Payout Ratio | 15.59% | 11.73% | 11.19% | 11.92% | 11.90% |